Image for post
Image for post
Future Medicine 2017 at the Kosmos Club in Berlin, Germany

Future Medicine 2017: Brilliant Bytes

A Berlin conference delivers an insightful high-speed forecast on translational medicine

So what made this practical experiment such a success?

Ready, Set, Go!

Image for post
Image for post
The ‘Meet the Speaker’ area offered a place for presenters to connect with the audience after each session
Image for post
Image for post
A Tweet Wall spread the word about discussion topics and audience reaction. It was an innovative way to keep visibly connected and cross-pollinate ideas.

A New Paradigm in Translational Medicine

Speaker Gallery

Image for post
Image for post
Dr. Elizabeth Ford from Brighton and Sussex Medical School presents “ASTRODEM: Using Astrophysics to Close the Diagnosis Gap for Dementia”
Image for post
Image for post
Dr. Ford then explains how a scientist’s skills can be grafted to patient record analysis and include AI.
Image for post
Image for post
Dr. Daniel Freitag from Bayer AG leverages nature’s randomized trials for drug discovery, explaining Pharma’s Catch 22: We need the drug in order to prove the need for the drug.
Image for post
Image for post
Dr. Nicole Kränkel from Charité -Universitätsmedizin Berlin presented “Neutrophils in Acute Myocardial Infarction – Dr. Jekyll and Mr. Hyde”. She llustrated how our immune cells called neutrophils (NT) thankfully catch pathogens ( disease-causing organisms) but can do so without any trigger, leading to tissue damage and inflammation near the heart. How do we promote angiogenesis (new blood vessel creation) without nudging these trigger-happy neutrophils?
Image for post
Image for post
Dr. Daniel Ziemek from Pfizer Cambridge explains how clinical trials can have more effective outcomes by taking a lesson from Google’s study of search imagery, echoing what Dr. Dudley touched on earlier: use AI to massively scale up the evaluation of electronic medical records to determine best candidates for clinical trials.
Image for post
Image for post
Dr. Florian Herse from the MDC in Berlin presented how early prediction of preeclampsia matters: the condition increases cardiovascular risks for both mother and child later in life and treatments are limited to lowering blood pressure. His studies suggest it’s better to take a blood sample early on to examine metabolites and assess risk of developing the condition.
Image for post
Image for post
Dr. Daniela Panáková, from the MDC in Berlin presents tough statistics. She investigates interactions between physiology and signaling pathways throughout development and applies that knowledge to understanding mechanisms underlying common disease states.
Image for post
Image for post
Dr. Kathleen Börner from Heidelberg University Hospital suggests using CRISPR to prevent HIV entry into cells and inactivate the HIV genome.
Image for post
Image for post
Thilo Liebscher from the Technical University of Applied Sciences at Wildau/University of Rome discusses online cell vitality monitoring in miniaturised cell culture while promoting non-animal testing.

If you weren’t there, join next year!

Image for post
Image for post

Reporting from within a Venn diagram of health, tech and empowerment. Berlin-based. Internationally minded.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store